When was Neo Modulus founded?

Neo Modulus was founded in 2017 and raised its 1st funding round 8 years after it was founded.

Where is Neo Modulus located?

Neo Modulus is headquartered in Shanghai, China.

Is Neo Modulus a funded company?

Neo Modulus is a funded company, having raised a total of $***** in its 1st and only funding round, a Series C round on Jan 14, 2025.

When was the latest funding round of Neo Modulus?

Neo Modulus' latest funding was a $***** Series C round on Jan 14, 2025, with participation from 1 investor.

Where does Neo Modulus rank among its competitors?

Neo Modulus ranks 14th amongst 36 active competitors, of which 7 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was GelSana, which secured $300K in Jul, 2025.

Who are the top competitors of Neo Modulus?

Neo Modulus' top competitors include BONESUPPORT, Kuros Biosciences and OssDsign. Among them, GelSana secured the most recent funding round in July, 2025.

Neo Modulus - 2026 Company Profile, Funding & Competitors

Neo Modulus is a series C company based in Shanghai (China), founded in 2017. It operates as a Developer of regenerative implantable medical devices for guided tissue regeneration and bone regeneration in trauma patients. Neo Modulus has raised $40.9M in funding from Shenzhen Capital Group. The company has 36 active competitors, including 7 funded and 4 that have exited. Its top competitors include companies like BONESUPPORT, Kuros Biosciences and OssDsign.

Company Details

Developer of regenerative implantable medical devices for guided tissue regeneration and bone regeneration in trauma patients. It offers Neocirrus Augmented Gingival Matrix a gelatin electrospinning matrix designed specifically for the gain of Keratinized Mucosa and enlarge vestibular sulcus depth in vestibuloplasty procedure.

Key Metrics

Founded Year

2017

Location

Shanghai, China

Stage

Series C

Total Funding

$40.9M in 1 round

Latest Funding Round

Series C, Jan 14, 2025, $*****

Investors

Shenzhen Capital Group & 1 more

Ranked

14^th among 36 active competitors

Similar Companies

BONESUPPORT & 37 more

View Neo Modulus' full profile

Neo Modulus has raised a total funding of $40.9M over 1 round. Its latest funding round was a Series C round on Jan 14, 2025 for $*****. 1 investor participated in its latest round. Neo Modulus has 2 institutional investors.

Here is the list of recent funding rounds of Neo Modulus:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 14, 2025	6406799	Series C	5825018	7041122	7334447	1134508

Access funding benchmarks and valuations. Sign up today!

View details of Neo Modulus's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Neo Modulus include BONESUPPORT, Kuros Biosciences and OssDsign. Here is the list of Top 10 competitors of Neo Modulus, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BONESUPPORT 2000, Lund (Sweden), Public	Injectable, synthetic bone substitutes for remodeling	$101M	Tellacq Partners, Stage Capital & 15 others	61/100
2nd	Kuros Biosciences 2000, Schlieren (Switzerland), Public	Provider of smart solutions for bone disease management	$24.6M	Renaissance, LifeCare Partners & 12 others	61/100
3rd	OssDsign 2011, Uppsala (Sweden), Public	Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma	$19.7M	Eiffel Investment Group, SEB & 10 others	59/100
4th	Alafair Biosciences 2011, Austin (United States), Series B	Biomaterials and biomedical devices that enhance internal wound healing	$13.7M	ATP, Austin Technology Incubator & 4 others	56/100
5th	ISTO Biologics 1997, St. Louis (United States), Acquired	Developer of treatments for cartilage and bone problems	$40.7M	Life Sciences Partners, EQT & 8 others	54/100
6th	GelSana 2020, Aurora (United States), Series A	Developer of novel hydrogels for wound healing	$4.83M	Innosphere Ventures, Innosphere Ventures & 4 others	49/100
7th	Locate Bio 2001, Nottingham (United Kingdom), Series A	Developer next generation of orthobiologics products for the treatment of injuries	$31.6M	Mercia, BGF & 18 others	44/100
8th	Matricelf 2019, Tel Aviv (Israel), Funding Raised	Developer of spinal cord implants and regenerative medicine for treating spinal injury	-	MassChallenge	40/100
9th	Askel Healthcare 2017, Helsinki (Finland), Funding Raised	Developer of regenerative medicines for cartilage & bone tissue regeneration	-	Dualcore, EIC Fund & 2 others	40/100
10th	Ventris Medical 2017, Newport Beach (United States), Unfunded	Provider of biologics and tissue healing products for orthopedic surgeons	-	-	34/100
14th	Neo Modulus 2017, Shanghai (China), Series C	Developer of regenerative implantable medical devices for guided tissue regeneration and bone regeneration in trauma patients	$40.9M	Hyfinity Investments, Shenzhen Capital Group	27/100